Fairmount Funds Management LLC

13F Holdings History for Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT)

Symbol: COGT on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Ownership: 15.9M shares
Security Ownership: 9.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Fairmount Funds Management LLC ownership in Cogent Biosciences, Inc. Common Stock, $0.001 par value (COGT)

2025-11-17 - Fairmount Funds Management LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15.9M shares of Cogent Biosciences, Inc. Common Stock, $0.001 par value (COGT). This represents 9.9% percent ownership of the company. In their previous filing dated 2025-07-14, Fairmount Funds Management LLC had reported owning 14.3M shares, indicating an increase of 10.8% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Fairmount Funds Management LLC	9.9%		$224M	15.9M	+1,552,500	+10.8%	$14.13	13D/A	11/13/2025	17 Nov 2025 16:36:40
Fairmount Funds Management LLC	9.9%		$73.5M	14.3M			$5.13	13D/A	7/10/2025	14 Jul 2025 16:31:11

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	11.6%	+3.59%	$129M	9M	+2,777,777	+44.6%	$14.36	Q3 2025
6/30/2025	5.79%		$44.7M	6.23M			$7.18	Q2 2025
3/31/2025	5.79%		$37.3M	6.23M			$5.99	Q1 2025
12/31/2024	4.83%		$48.6M	6.23M			$7.80	Q4 2024
9/30/2024	5.45%		$67.2M	6.23M			$10.80	Q3 2024
6/30/2024	5.93%	+1.38%	$52.5M	6.23M	+1,500,000	+31.7%	$8.43	Q2 2024
3/31/2024	3.46%	+0.83%	$31.8M	4.73M	+1,166,666	+32.8%	$6.72	Q1 2024
12/31/2023	2.21%		$20.9M	3.56M			$5.88	Q4 2023
9/30/2023	4.17%		$34.7M	3.56M			$9.75	Q3 2023
6/30/2023	5.94%	+1.34%	$42.1M	3.56M	+800,000	+29%	$11.84	Q2 2023
3/31/2023	5.12%		$29.8M	2.76M			$10.79	Q1 2023
12/31/2022	5.06%		$31.9M	2.76M			$11.56	Q4 2022
9/30/2022	7.24%		$41.2M	2.76M			$14.92	Q3 2022
6/30/2022	5.7%	+2.48%	$24.9M	2.76M	+1,200,000	+77%	$9.02	Q2 2022
3/31/2022	2.76%		$11.7M	1.56M			$7.49	Q1 2022
12/31/2021	4.41%		$13.4M	1.56M			$8.58	Q4 2021
9/30/2021	4.77%		$13.1M	1.56M			$8.41	Q3 2021
6/30/2021	5.2%		$12.6M	1.56M			$8.11	Q2 2021
3/31/2021	5.77%		$13.7M	1.56M			$8.78	Q1 2021
12/31/2020	6.26%	+6.26%	$17.5M	1.56M	+1,558,975	NEW	$11.23	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.